カテーテル関連血流感染の世界市場レポート 2024年

カテーテル関連血流感染市場規模は、今後数年間で力強い成長が見込まれます。2028年にはCAGR6.1％で19億3,000万米ドルに成長します。予測期間における成長の要因としては、医療関連感染（HAI）の蔓延、感染対策に対する意識の高まりとトレーニングの実施、医療インフラの拡大、高齢者人口の増加、政府の支援政策やイニシアティブなどが挙げられます。この期間に予想される主要動向には、生体材料の革新、スマートカテーテル技術の進歩、高度な抗菌特性を備えたより効果的なカテーテルロックソリューションの開発、カテーテル滅菌プロセスの革新、自動洗浄システムの導入などがあります。

院内感染の発生率の増加が、今後のカテーテル関連血流感染市場の成長を促進すると予想されます。院内感染（HAI）は、患者が医療環境で他の疾患の治療を受けている間に感染する感染症で、通常は入院後48時間以上経過してから発症します。院内感染増加の要因としては、抗菌薬耐性、不十分な感染制御プロトコル、患者の脆弱性などが挙げられます。カテーテル関連血流感染症は、カテーテルの侵襲的な性質と微生物によるコロニー形成の可能性から、HAIの中でも特に問題視されており、留置カテーテルを使用している患者にリスクをもたらしています。例えば、National Library of Medicineは2023年1月に、世界の医療関連感染（HAI）率は0.14％で、毎年0.06％ずつ増加していると報告しています。したがって、院内感染の蔓延は、カテーテル関連血流感染市場の成長を促進することになります。

カテーテル関連血流感染市場の新興国開拓企業は、感染予防を強化し患者の転帰を改善するため、カテーテルロック療法などの革新的ソリューションの開発に注力しています。カテーテルロック療法は、カテーテルに液体を注入して感染を予防し、カテーテルの開存性を維持するものです。例えば、2023年11月、米国を拠点とする治療用製品を専門とするバイオ医薬品企業であるCorMedix Inc.は、DefenCath（タウロリジンとヘパリン）カテーテルロック溶液のFDA承認を取得しました。このソリューションは、中心静脈カテーテル（CVC）を通して慢性血液透析を受けている腎不全の成人患者向けに調整されたもので、抗凝固のためのヘパリンと、カテーテル関連血流感染（CRBSI）を減らすためのタウロリジンの幅広い抗菌特性を併せ持つ。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 マクロ経済シナリオ

• 高インフレが市場に与える影響
• ウクライナ・ロシア戦争が市場に与える影響
• COVID-19による市場への影響

第5章 世界の市場規模と成長

• 世界のカテーテル関連血流感染市場：促進要因と抑制要因
  • 市場促進要因
  • 市場抑制要因
• 世界のカテーテル関連血流感染市場の実績：規模と成長、2018～2023年
• 世界のカテーテル関連血流感染市場の予測：規模と成長、2023～2028年、2033年

第6章 市場セグメンテーション

• 世界のカテーテル関連血流感染市場：治療別、実績と予測、2018～2023年、2023～2028年、2033年
• 抗生物質ロック療法
• 抗菌剤
• 世界のカテーテル関連血流感染市場：感染源または原因物質別、実績と予測、2018～2023年、2023～2028年、2033年
• 黄色ブドウ球菌
• アシネトバクター・バウマニ
• 大腸菌（E. Coli）
• クレブシエラ・ニューモニエ（K. Pneumonia）
• カンジダ属（カンジダ属）
• 緑膿菌（P. Aeruginosa）
• その他の感染源または原因物質
• 世界のカテーテル関連血流感染市場：流通チャネル別、実績と予測、2018～2023年、2023～2028年、2033年
• 病院薬局
• 小売薬局
• オンライン薬局

第7章 地域別・国別分析

• 世界のカテーテル関連血流感染市場：地域別、実績と予測、2018～2023年、2023～2028年、2033年
• 世界のカテーテル関連血流感染市場：国別、実績と予測、2018～2023年、2023～2028年、2033年

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• カテーテル関連血流感染市場：競合情勢
• カテーテル関連血流感染市場：企業プロファイル
  • Pfizer Inc.
  • Johnson & Johnson Services Inc.
  • Novartis AG
  • 3M Company
  • Eli Lilly and Company

第31章 その他の大手企業と革新的企業

• Fresenius Medical Care AG & Co. KGaA
• Becton Dickinson and Company
• Viatris Inc.
• B. Braun Medical Inc.
• Aurobindo Pharma Limited
• Lupin Ltd.
• Xellia Pharmaceuticals Ltd.
• SteriMax Inc.
• Geistlich Pharma AG
• Bactiguard AB
• Hetero Healthcare Ltd.
• TauroPharm GmbH
• Advacare Pharma
• Citus Pharmaceuticals Inc.
• CorMedix Inc.

第32章 競合ベンチマーキング

第33章 競合ダッシュボード

第34章 主要な合併と買収

第35章 将来の展望と潜在的な分析

第36章 付録

Catheter-related bloodstream infection (CRBSI) is a serious healthcare-associated infection caused by bacteria or fungi entering the bloodstream through a catheter-a tube used to administer medications or nutrients directly into a vein. This condition can lead to sepsis and other severe complications, emphasizing the critical need for prompt diagnosis and treatment.

The primary treatments for CRBSI include antibiotic lock therapy and antimicrobial agents. Antibiotic lock therapy involves infusing a concentrated antibiotic solution into the catheter lumen, where it remains for an extended period to prevent or eliminate catheter-related infections locally, without systemic administration. This approach is frequently employed in patients with central venous catheters to manage and prevent CRBSI. Common sources of infection and causative agents include Staphylococcus aureus, Acinetobacter baumannii, Escherichia coli (E. coli), Klebsiella pneumoniae (K. pneumoniae), Candida species, Pseudomonas aeruginosa, among others. These treatments are available through hospital pharmacies, retail pharmacies, and online pharmacies.

The catheter-related bloodstream infection research report is one of a series of new reports from The Business Research Company that provides catheter-related bloodstream infection market statistics, including the catheter-related bloodstream infection industry's global market size, regional shares, competitors with a catheter-related bloodstream infection market share, detailed catheter-related bloodstream infection market segments, market trends and opportunities, and any further data you may need to thrive in the catheter-related bloodstream infection industry. This catheter-related bloodstream infection market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The catheter-related bloodstream infection market size has grown strongly in recent years. It will grow from $1.44 billion in 2023 to $1.53 billion in 2024 at a compound annual growth rate (CAGR) of 5.9%. The growth observed in the historic period can be attributed to several key factors, an increase in the incidence of chronic diseases, heightened awareness and education regarding healthcare, a rise in hospital-acquired infections, the growing elderly population, and the implementation of enhanced infection control programs in hospitals and healthcare settings.

The catheter-related bloodstream infection market size is expected to see strong growth in the next few years. It will grow to $1.93 billion in 2028 at a compound annual growth rate (CAGR) of 6.1%. In the forecast period, growth can be attributed to several factors, the increasing prevalence of healthcare-associated infections (HAIs), heightened awareness and training on infection control practices, expansion of healthcare infrastructure, a growing geriatric population, and supportive government policies and initiatives. Major trends anticipated during this period include innovations in biomaterials, advancements in smart catheter technology, the development of more effective catheter lock solutions with advanced antimicrobial properties, innovations in catheter sterilization processes, and the introduction of automated flushing systems.

The increasing incidence of hospital-acquired infections is anticipated to drive growth in the market for catheter-related bloodstream infections in the future. Hospital-acquired infections (HAIs) are infections that patients contract while undergoing treatment for other conditions in healthcare settings, typically emerging 48 hours or more after admission. Factors contributing to the rise in hospital-acquired infections include antimicrobial resistance, inadequate infection control protocols, and patient vulnerability. Catheter-related bloodstream infections are particularly problematic within HAIs due to the invasive nature of catheters and their potential for microbial colonization, posing risks to patients with indwelling catheters. For example, the National Library of Medicine reported in January 2023 that the global healthcare-associated infection (HAI) rate was 0.14%, with an annual increase of 0.06%. Hence, the escalating prevalence of hospital-acquired infections is set to propel growth in the catheter-related bloodstream infection market.

Leading companies in the catheter-related bloodstream infection market are focusing on developing innovative solutions such as catheter lock therapies to enhance infection prevention and improve patient outcomes. A catheter lock solution involves instilling a liquid into a catheter to prevent infections and maintain catheter patency between uses. For instance, in November 2023, CorMedix Inc., a US-based biopharmaceutical firm specializing in therapeutic products, received FDA approval for DefenCath (taurolidine and heparin) catheter lock solution. This solution is tailored for adult patients with kidney failure undergoing chronic hemodialysis through central venous catheters (CVCs), combining heparin for anticoagulation with taurolidine's broad-spectrum antimicrobial properties to reduce catheter-related bloodstream infections (CRBSIs).

In April 2022, CEMMA Medical Company Limited, based in Taiwan, partnered with LipoCoat BV to develop a coated central venous catheter (CVC) aimed at sustainable infection control. This collaboration leverages CEMMA's expertise in catheter technology and LipoCoat's bio-inspired coating technology, aiming to deliver an advanced CVC solution to combat the global challenge of healthcare-associated infections. LipoCoat BV, headquartered in the Netherlands, specializes in bio-inspired coating technologies.

Major companies operating in the catheter-related bloodstream infection market are Pfizer Inc., Johnson & Johnson Services Inc., Novartis AG, 3M Company, Eli Lilly and Company, Fresenius Medical Care AG & Co. KGaA, Becton Dickinson and Company, Viatris Inc., B. Braun Medical Inc., Aurobindo Pharma Limited, Lupin Ltd., Xellia Pharmaceuticals Ltd., SteriMax Inc., Geistlich Pharma AG, Bactiguard AB, Hetero Healthcare Ltd., TauroPharm GmbH, Advacare Pharma, Citus Pharmaceuticals Inc., CorMedix Inc., JoinHub Pharma LLP, IntegraDose Compounding Services LLC

North America was the largest region in the catheter-related bloodstream infection market in 2023. The regions covered in the catheter-related bloodstream infection market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the catheter-related bloodstream infection market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The catheter-related bloodstream infection market consists of revenues earned by entities by providing services such as blood culture testing, catheter flushing and maintenance, aseptic catheter insertion, hand hygiene training, and compliance monitoring. The market value includes the value of related goods sold by the service provider or included within the service offering. The catheter-related bloodstream infection market also includes sales of catheters, catheter insertion kits, catheter maintenance equipment, monitoring and diagnostic devices, and infection control equipment. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Catheter-Related Bloodstream Infection Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on catheter-related bloodstream infection market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
• Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
• Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
• Measure the impact of high global inflation on market growth.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for catheter-related bloodstream infection ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The catheter-related bloodstream infection market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of COVID-19 on supply chains and consumption patterns.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Treatment: Antibiotic Lock Therapy; Anti-Microbial Agents
• 2) By Source Of Infection Or Causative Agents: Staphylococcus Aureus; Acinetobacter Baumannii; Escherichia Coli (E. Coli); Klebsiella Pneumoniae (K. Pneumonia); Candida Species (Candida Sp.); Pseudomonas Aeruginosa (P. Aeruginosa); Other Source Of Infection Or Causative Agents
• 3) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Online Pharmacies
• Companies Mentioned: Pfizer Inc.; Johnson & Johnson Services Inc.; Novartis AG; 3M Company; Eli Lilly and Company
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Catheter-Related Bloodstream Infection Market Characteristics

3. Catheter-Related Bloodstream Infection Market Trends And Strategies

4. Catheter-Related Bloodstream Infection Market - Macro Economic Scenario

• 4.1. Impact Of High Inflation On The Market
• 4.2. Ukraine-Russia War Impact On The Market
• 4.3. COVID-19 Impact On The Market

5. Global Catheter-Related Bloodstream Infection Market Size and Growth

• 5.1. Global Catheter-Related Bloodstream Infection Market Drivers and Restraints
  • 5.1.1. Drivers Of The Market
  • 5.1.2. Restraints Of The Market
• 5.2. Global Catheter-Related Bloodstream Infection Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
• 5.3. Global Catheter-Related Bloodstream Infection Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Catheter-Related Bloodstream Infection Market Segmentation

• 6.1. Global Catheter-Related Bloodstream Infection Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Antibiotic Lock Therapy
• Anti-Microbial Agents
• 6.2. Global Catheter-Related Bloodstream Infection Market, Segmentation By Source Of Infection Or Causative Agents, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Staphylococcus Aureus
• Acinetobacter Baumannii
• Escherichia Coli (E. Coli)
• Klebsiella Pneumoniae (K. Pneumonia)
• Candida Species (Candida Sp.)
• Pseudomonas Aeruginosa (P. Aeruginosa)
• Other Source Of Infection Or Causative Agents
• 6.3. Global Catheter-Related Bloodstream Infection Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies

7. Catheter-Related Bloodstream Infection Market Regional And Country Analysis

• 7.1. Global Catheter-Related Bloodstream Infection Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 7.2. Global Catheter-Related Bloodstream Infection Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Catheter-Related Bloodstream Infection Market

• 8.1. Asia-Pacific Catheter-Related Bloodstream Infection Market Overview
• Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Catheter-Related Bloodstream Infection Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 8.3. Asia-Pacific Catheter-Related Bloodstream Infection Market, Segmentation By Source Of Infection Or Causative Agents, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 8.4. Asia-Pacific Catheter-Related Bloodstream Infection Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Catheter-Related Bloodstream Infection Market

• 9.1. China Catheter-Related Bloodstream Infection Market Overview
• 9.2. China Catheter-Related Bloodstream Infection Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
• 9.3. China Catheter-Related Bloodstream Infection Market, Segmentation By Source Of Infection Or Causative Agents, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
• 9.4. China Catheter-Related Bloodstream Infection Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Catheter-Related Bloodstream Infection Market

• 10.1. India Catheter-Related Bloodstream Infection Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 10.2. India Catheter-Related Bloodstream Infection Market, Segmentation By Source Of Infection Or Causative Agents, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 10.3. India Catheter-Related Bloodstream Infection Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Catheter-Related Bloodstream Infection Market

• 11.1. Japan Catheter-Related Bloodstream Infection Market Overview
• 11.2. Japan Catheter-Related Bloodstream Infection Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 11.3. Japan Catheter-Related Bloodstream Infection Market, Segmentation By Source Of Infection Or Causative Agents, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 11.4. Japan Catheter-Related Bloodstream Infection Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Catheter-Related Bloodstream Infection Market

• 12.1. Australia Catheter-Related Bloodstream Infection Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 12.2. Australia Catheter-Related Bloodstream Infection Market, Segmentation By Source Of Infection Or Causative Agents, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 12.3. Australia Catheter-Related Bloodstream Infection Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Catheter-Related Bloodstream Infection Market

• 13.1. Indonesia Catheter-Related Bloodstream Infection Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 13.2. Indonesia Catheter-Related Bloodstream Infection Market, Segmentation By Source Of Infection Or Causative Agents, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 13.3. Indonesia Catheter-Related Bloodstream Infection Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Catheter-Related Bloodstream Infection Market

• 14.1. South Korea Catheter-Related Bloodstream Infection Market Overview
• 14.2. South Korea Catheter-Related Bloodstream Infection Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 14.3. South Korea Catheter-Related Bloodstream Infection Market, Segmentation By Source Of Infection Or Causative Agents, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 14.4. South Korea Catheter-Related Bloodstream Infection Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Catheter-Related Bloodstream Infection Market

• 15.1. Western Europe Catheter-Related Bloodstream Infection Market Overview
• 15.2. Western Europe Catheter-Related Bloodstream Infection Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 15.3. Western Europe Catheter-Related Bloodstream Infection Market, Segmentation By Source Of Infection Or Causative Agents, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 15.4. Western Europe Catheter-Related Bloodstream Infection Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Catheter-Related Bloodstream Infection Market

• 16.1. UK Catheter-Related Bloodstream Infection Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 16.2. UK Catheter-Related Bloodstream Infection Market, Segmentation By Source Of Infection Or Causative Agents, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 16.3. UK Catheter-Related Bloodstream Infection Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Catheter-Related Bloodstream Infection Market

• 17.1. Germany Catheter-Related Bloodstream Infection Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 17.2. Germany Catheter-Related Bloodstream Infection Market, Segmentation By Source Of Infection Or Causative Agents, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 17.3. Germany Catheter-Related Bloodstream Infection Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Catheter-Related Bloodstream Infection Market

• 18.1. France Catheter-Related Bloodstream Infection Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 18.2. France Catheter-Related Bloodstream Infection Market, Segmentation By Source Of Infection Or Causative Agents, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 18.3. France Catheter-Related Bloodstream Infection Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Catheter-Related Bloodstream Infection Market

• 19.1. Italy Catheter-Related Bloodstream Infection Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 19.2. Italy Catheter-Related Bloodstream Infection Market, Segmentation By Source Of Infection Or Causative Agents, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 19.3. Italy Catheter-Related Bloodstream Infection Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Catheter-Related Bloodstream Infection Market

• 20.1. Spain Catheter-Related Bloodstream Infection Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 20.2. Spain Catheter-Related Bloodstream Infection Market, Segmentation By Source Of Infection Or Causative Agents, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 20.3. Spain Catheter-Related Bloodstream Infection Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Catheter-Related Bloodstream Infection Market

• 21.1. Eastern Europe Catheter-Related Bloodstream Infection Market Overview
• 21.2. Eastern Europe Catheter-Related Bloodstream Infection Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 21.3. Eastern Europe Catheter-Related Bloodstream Infection Market, Segmentation By Source Of Infection Or Causative Agents, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 21.4. Eastern Europe Catheter-Related Bloodstream Infection Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Catheter-Related Bloodstream Infection Market

• 22.1. Russia Catheter-Related Bloodstream Infection Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 22.2. Russia Catheter-Related Bloodstream Infection Market, Segmentation By Source Of Infection Or Causative Agents, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 22.3. Russia Catheter-Related Bloodstream Infection Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Catheter-Related Bloodstream Infection Market

• 23.1. North America Catheter-Related Bloodstream Infection Market Overview
• 23.2. North America Catheter-Related Bloodstream Infection Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 23.3. North America Catheter-Related Bloodstream Infection Market, Segmentation By Source Of Infection Or Causative Agents, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 23.4. North America Catheter-Related Bloodstream Infection Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Catheter-Related Bloodstream Infection Market

• 24.1. USA Catheter-Related Bloodstream Infection Market Overview
• 24.2. USA Catheter-Related Bloodstream Infection Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 24.3. USA Catheter-Related Bloodstream Infection Market, Segmentation By Source Of Infection Or Causative Agents, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 24.4. USA Catheter-Related Bloodstream Infection Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Catheter-Related Bloodstream Infection Market

• 25.1. Canada Catheter-Related Bloodstream Infection Market Overview
• 25.2. Canada Catheter-Related Bloodstream Infection Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 25.3. Canada Catheter-Related Bloodstream Infection Market, Segmentation By Source Of Infection Or Causative Agents, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 25.4. Canada Catheter-Related Bloodstream Infection Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Catheter-Related Bloodstream Infection Market

• 26.1. South America Catheter-Related Bloodstream Infection Market Overview
• 26.2. South America Catheter-Related Bloodstream Infection Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 26.3. South America Catheter-Related Bloodstream Infection Market, Segmentation By Source Of Infection Or Causative Agents, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 26.4. South America Catheter-Related Bloodstream Infection Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Catheter-Related Bloodstream Infection Market

• 27.1. Brazil Catheter-Related Bloodstream Infection Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 27.2. Brazil Catheter-Related Bloodstream Infection Market, Segmentation By Source Of Infection Or Causative Agents, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 27.3. Brazil Catheter-Related Bloodstream Infection Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Catheter-Related Bloodstream Infection Market

• 28.1. Middle East Catheter-Related Bloodstream Infection Market Overview
• 28.2. Middle East Catheter-Related Bloodstream Infection Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 28.3. Middle East Catheter-Related Bloodstream Infection Market, Segmentation By Source Of Infection Or Causative Agents, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 28.4. Middle East Catheter-Related Bloodstream Infection Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Catheter-Related Bloodstream Infection Market

• 29.1. Africa Catheter-Related Bloodstream Infection Market Overview
• 29.2. Africa Catheter-Related Bloodstream Infection Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 29.3. Africa Catheter-Related Bloodstream Infection Market, Segmentation By Source Of Infection Or Causative Agents, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 29.4. Africa Catheter-Related Bloodstream Infection Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Catheter-Related Bloodstream Infection Market Competitive Landscape And Company Profiles

• 30.1. Catheter-Related Bloodstream Infection Market Competitive Landscape
• 30.2. Catheter-Related Bloodstream Infection Market Company Profiles
  • 30.2.1. Pfizer Inc.
    • 30.2.1.1. Overview
    • 30.2.1.2. Products and Services
    • 30.2.1.3. Strategy
    • 30.2.1.4. Financial Performance
  • 30.2.2. Johnson & Johnson Services Inc.
    • 30.2.2.1. Overview
    • 30.2.2.2. Products and Services
    • 30.2.2.3. Strategy
    • 30.2.2.4. Financial Performance
  • 30.2.3. Novartis AG
    • 30.2.3.1. Overview
    • 30.2.3.2. Products and Services
    • 30.2.3.3. Strategy
    • 30.2.3.4. Financial Performance
  • 30.2.4. 3M Company
    • 30.2.4.1. Overview
    • 30.2.4.2. Products and Services
    • 30.2.4.3. Strategy
    • 30.2.4.4. Financial Performance
  • 30.2.5. Eli Lilly and Company
    • 30.2.5.1. Overview
    • 30.2.5.2. Products and Services
    • 30.2.5.3. Strategy
    • 30.2.5.4. Financial Performance

31. Catheter-Related Bloodstream Infection Market Other Major And Innovative Companies

• 31.1. Fresenius Medical Care AG & Co. KGaA
• 31.2. Becton Dickinson and Company
• 31.3. Viatris Inc.
• 31.4. B. Braun Medical Inc.
• 31.5. Aurobindo Pharma Limited
• 31.6. Lupin Ltd.
• 31.7. Xellia Pharmaceuticals Ltd.
• 31.8. SteriMax Inc.
• 31.9. Geistlich Pharma AG
• 31.10. Bactiguard AB
• 31.11. Hetero Healthcare Ltd.
• 31.12. TauroPharm GmbH
• 31.13. Advacare Pharma
• 31.14. Citus Pharmaceuticals Inc.
• 31.15. CorMedix Inc.

32. Global Catheter-Related Bloodstream Infection Market Competitive Benchmarking

33. Global Catheter-Related Bloodstream Infection Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Catheter-Related Bloodstream Infection Market

35. Catheter-Related Bloodstream Infection Market Future Outlook and Potential Analysis

• 35.1 Catheter-Related Bloodstream Infection Market In 2028 - Countries Offering Most New Opportunities
• 35.2 Catheter-Related Bloodstream Infection Market In 2028 - Segments Offering Most New Opportunities
• 35.3 Catheter-Related Bloodstream Infection Market In 2028 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer